Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Single Women”

3,626 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,626 results

Not applicableUnknownNCT02054858
What this trial is testing

Preconditioning Against Renal Damage Under Contrast Examination

Who this might be right for
Acute Kidney Injury
Mid Western Regional Hospital, Ireland 1,000
Not applicableStudy completedNCT03900364
What this trial is testing

A Prospective Trial Comparing Robot-assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy

Who this might be right for
Carcinoma, Renal CellRenal Malignant TumorRenal Cyst+1 more
Salzburger Landeskliniken 30
Testing effectiveness (Phase 2)Study completedNCT02650193
What this trial is testing

The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.

Who this might be right for
Non-metastatic Breast Cancer
Pfizer 25
Not applicableEnded earlyNCT06752135
What this trial is testing

Node Positive Cervical Cancer Treated by Neoadjuvant Chemotherapy Plus Radical Surgery: a Single Center Experience

Who this might be right for
Cervical Carcinoma
Azienda Policlinico Umberto I 97
Not applicableStudy completedNCT00440908
What this trial is testing

Inflammation and Nutritional Parameters in Hemodialysis Patients Using Reprocessed Dialyzers

Who this might be right for
End Stage Renal DiseaseInflammation
Fresenius Medical Care North America 2,500
Early research (Phase 1)Study completedNCT00254800
What this trial is testing

The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 38
Large-scale testing (Phase 3)Active Not RecruitingNCT05943106
What this trial is testing

BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants

Who this might be right for
Non-Muscle- Invasive Bladder Cancer
AstraZeneca 100
Large-scale testing (Phase 3)Study completedNCT00103233
What this trial is testing

Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network
Post-approval studies (Phase 4)UnknownNCT04300452
What this trial is testing

Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage

Who this might be right for
Postpartum Hemorrhage
National and Kapodistrian University of Athens 100
Not applicableNot Yet RecruitingNCT06588192
What this trial is testing

Renal Survival in Patients with Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Assiut University 97
Not applicableStudy completedNCT07398014
What this trial is testing

The New Possibility of Treating Overactive Bladder With Radiofrequency

Who this might be right for
Overactive Bladder and Urge Urinary Incontinence
University Maribor 95
Not applicableStudy completedNCT06733194
What this trial is testing

Complications of Bladder Augmentation in Children

Who this might be right for
Neurogenic Bladder DisorderSpina BifidaComplications of Surgical Procedures or Medical Care+2 more
University Hospital, Clermont-Ferrand 87
Early research (Phase 1)Active Not RecruitingNCT05614102
What this trial is testing

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bayer 284
Testing effectiveness (Phase 2)WithdrawnNCT04149275
What this trial is testing

Cabozantinib Plus Nivolumab and Ipilimumab in Women With Recurrent Gynecologic Carcinosarcoma

Who this might be right for
Carcinosarcoma of OvaryCarcinosarcoma of UterusCarcinosarcoma of Vagina
University of Alabama at Birmingham
Early research (Phase 1)Study completedNCT04926701
What this trial is testing

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy Subjects

Who this might be right for
Cystic Fibrosis
Enterprise Therapeutics Ltd 98
Large-scale testing (Phase 3)Study completedNCT04209114
What this trial is testing

Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer

Who this might be right for
Bladder CancerBladder TumorMuscle-Invasive Bladder Cancer
Bristol-Myers Squibb 114
Not applicableNo Longer AvailableNCT03874455
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Who this might be right for
Epithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more
Epizyme, Inc.
Not applicableStudy completedNCT03600064
What this trial is testing

Misoprostol for Cervical Ripening Before Copper Intrauterine Device Removal

Who this might be right for
Intrauterine Device
Assiut University 80
Testing effectiveness (Phase 2)Study completedNCT01591447
What this trial is testing

Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital Gonorrhea

Who this might be right for
Uncomplicated Urogenital Gonorrhea
Melinta Therapeutics, Inc. 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07189793
What this trial is testing

Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study

Who this might be right for
Urinary Bladder NeoplasmsCarcinoma, Transitional CellCarcinoma in Situ of Bladder+1 more
First Affiliated Hospital of Wenzhou Medical University 106
Load More Results